Also found in: Dictionary, Thesaurus, Acronyms, Idioms, Encyclopedia, Wikipedia.


Farlex Partner Medical Dictionary © Farlex 2012


Reduced sweat production
I Inherited conditions, eg hereditary anhydrotic ectodermal dysplasia, ichthyosis, or angiokeratoma corporis diffusum universale
II Acquired conditions
 Collagen vascular diseases–-Sjögren syndrome, progressive systemic sclerosis
 Dermatopathies–Miliaria profunda, pemphigus vulgaris, psoriasis
 Drugs Anticholinergics, eg atropine, scopolamine; ganglionic blockers
 Endocrinopathies Diabetes insipidus, hypothyroidism, hypothalamic lesions
 Environmental stress Heat stroke and dehydration
Peripheral neuropathy Alcohol, amyloidosis, DM, Horner syndrome, leprosy  


Benign enlargement of ♂ breast that most commonly affects boys and adolescents, often regresses at puberty; it is usually due to a proliferation of glandular component; may occur in Klinefelter syndrome or after malnutrition Age-related peaks
1. Perinatal, in 60-90% of ♂ at birth, due to transplacental passage of estrogens.
2. Pubertal, up to 70%, depending on stringency of definition.
3. Involutional, age 50-80% Treatment Clomiphene, tamoxifen, testolactone, surgery. See Adolescent gynecomastia.
Gynecomastia Etiology
Endocrinopathy Orchitis, hypogonadism–androgen deficiency, androgen resistance, tumors/hyperplasia of adrenal gland, testes, eg Leydig cell tumor–↑ hCG, lung CA, Klinefelter syndrome–↑ risk of breast CA and thyroid hyperplasia
Drugs α-methyldopa, amphetamine, androgens, benzodiazepines, cimetidine, chemotherapeutics, digitalis, INH, marijuana, penicillamine, phenothiazine, reserpine, spironolactone, tricyclic antidepressants
Other conditions Starvation diet–mechanism: testicular, hepatic hypofunction or on resuming feeding, hemodialysis, liver disease–cirrhosis, hepatomas, hemochromatosis, due to ↓ hepatic metabolism of estrogens, mycosis fungoides, myotonic dystrophy with spastic paraplegia, leprosy
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
* Wrap up the lesson by asking students, How would you respond to a friend who says, "I know that using drugs reduces stress"?
A recent study by economist Benjamin Zycher published by the Manhattan Institute for Policy Research shows that whatever saving appears to be realized by government negotiating will be more than offset by greater human suffering because of fewer new and beneficial drugs. There would inevitably be lower industry returns and a reduction in spending on research and development.
Unlike traditional drugs, biologics do not currently have a Food and Drug Administration review and approval process for biogeneric drugs once the innovator drug's patent has expired.
First, we conducted a literature review to identify current estimates of prevalence and the adverse consequences associated with use of these drugs. We included physical and medical harms, psychological harms, and adverse social and developmental consequences.
IN PREPARATION FOR THIS month's column on best practices for employee and pre-employment drug testing, human resource departments at more than 25 colleges and universities nationwide were contacted.
To the Editor: Global surveillance of drug resistance has shown that a substantial proportion of tuberculosis (TB) patients are infected with drug-resistant Mycobacterium tuberculosis strains (1).
* establish a fund to show which drugs produce positive outcomes;
The prescription drugs most often abused by teens are painkillers, antianxiety medications (benzodiazepines), stimulants, and steroids--powerful drugs that carry real health risks.
He brilliantly exposes the mismatch between marketers' perception of drugs as just another consumer product, no different from cars or computers, and the fact that all drugs can have side effects, some of them more dangerous than others.
Food and Drug Administration in June, BiDil, the first drug marketed specifically for treatment of heart failure among African Americans, has aroused suspicion about its safety and set off a debate about attitudes surrounding race and medical research.
They also show up in the qualms of psychiatrists who worry that these drugs can be dangerous short cuts and in the public statements of regulators who suggest they're overused.